Serum levels of proamylin and amylin in normal subjects and patients with impaired glucose regulation and type 2 diabetes mellitus

Acta Diabetologica

Volumn 47, Issue 3, 2010, Pages 265-270

  Zheng, Xiaoya ^a   Ren, Wei ^a   Zhang, Suhua ^a   Liu, Jingjing ^a   Li, Sufang ^a   Li, Jinchao ^a   Yang, Ping ^a   He, Jun ^a   Su, Shaochu ^a   Li, Ping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Amylin; Insulin resistance; Proamylin; Type 2 diabetes mellitus

Indexed keywords

AMYLIN; AMYLIN DERIVATIVE; PROAMYLIN; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; ISLET AMYLOID POLYPEPTIDE; LIPIDS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SERUM;

EID: 77955715434     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0201-9     Document Type: Article

References (36)

1. SE Kahn 2003 The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes Diabetologia 46 3 19 10.1007/s00125-003-1190-9 1:CAS:528:DC%2BD3sXhtVKkt74%3D 12637977
2. M Manco U Giordano A Turchetta, et al. 2009 Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease Acta Diabetol 46 2 97 104 10.1007/s00592-008-0063-6 1:CAS:528:DC%2BD1MXlsFKksrs%3D 18839055
3. AE Butler J Janson S Bonner-Weir, et al. 2003 β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110 10.2337/diabetes.52.1.102 1:CAS:528:DC%2BD3sXisVaisA%3D%3D 12502499 (Pubitemid 36042113)
4. SM Ruchat CE Elks RJ Loos, et al. 2009 Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies Acta Diabetol 46 3 217 226 10.1007/s00592-008-0080-5 1:CAS:528:DC%2BD1MXptVGmsrk%3D 19082521
5. CJ Rhodes 2005 Type 2 diabetes: a matter of beta-cell life and death? Science 307 380 384 10.1126/science.1104345 1:CAS:528:DC%2BD2MXksFyhtg%3D%3D 15662003 (Pubitemid 40139973)
6. DA Chistiakov VA Potapov DC Khodirev, et al. 2009 Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes Acta Diabetol 46 1 43 49 10.1007/s00592-008- 0056-5 1:CAS:528:DC%2BD1MXht1Orsrc%3D 18758683
7. SE Kahn S Andrikopoulos CB Verchere 1999 Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes Diabetes 48 241 253 10.2337/diabetes.48.2.241 1:CAS:528:DyaK1MXpsFKguw%3D%3D 10334297 (Pubitemid 29061094)
8. A Clark MR Nilsson 2004 Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes? Diabetologia 47 157 169 10.1007/s00125-003-1304-4 1:CAS:528:DC%2BD2cXjtFCktLY%3D 14722650 (Pubitemid 38315352)
9. M Federici M Hribal L Perego, et al. 2001 High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program Diabetes 50 6 1290 1301 10.2337/diabetes.50.6.1290 1:CAS:528: DC%2BD3MXkvFSgsLk%3D 11375329
10. SI Chisalita T Lindström P Eson Jennersjö, et al. 2009 Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control Acta Diabetol 46 1 35 42 10.1007/s00592-008-0055-6 1:CAS:528:DC%2BD1MXht1Ors74%3D 18777156
11. E Hartter T Svoboda B Ludvik, et al. 1991 Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans Diabetologia 34 52 54 10.1007/BF00404025 1:CAS:528:DyaK3MXltleiu7Y%3D 2055340
12. SE Kahn DA D'Alessio MW Schwartz, et al. 1990 Evidence of cosecretion of islet amyloid polypeptide and insulin by beta cells Diabetes 39 634 638 10.2337/diabetes.39.5.634 1:CAS:528:DyaK3cXktVSrsb0%3D 2185112
13. A Clark SB Charge MK Badman, et al. 1996 Islet amyloid polypeptide: actions and role in the pathogenesis of diabetes Biochem Soc Trans 24 594 599 1:CAS:528:DyaK28XjtlKrtbk%3D 8736810
14. Guardado-Mendoza R, Davalli AM, Chavez AO, et al (2009) Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci 18; 106(33):13992-13997
15. CJ Huang CY Lin L Haataja, et al. 2007 High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes Diabetes 56 8 2016 2027 10.2337/db07-0197 1:CAS:528:DC%2BD2sXos12qs7w%3D 17475933 (Pubitemid 47201819)
16. AE Butler J Janson WC Soeller, et al. 2003 Increased beta cell apoptosis prevents adaptive increase in beta cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 2304 2314 10.2337/diabetes.52.9.2304 1:CAS:528: DC%2BD3sXntFeqtbY%3D 12941770 (Pubitemid 37059501)
17. AE Butler J Jang T Gurlo, et al. 2004 Diabetes due to a progressive defect in beta cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat): a new model for type 2 diabetes Diabetes 53 1509 1516 10.2337/diabetes.53.6.1509 1:CAS:528:DC%2BD2cXkslCgs7o%3D 15161755 (Pubitemid 38697663)
18. S Zraika RL Hull J Udayasankar, et al. 2009 Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis Diabetologia 52 4 626 635 10.1007/s00125-008-1255-x 1:CAS:528:DC%2BD1MXisFSisrs%3D 19148619
19. AV Matveyenko T Gurlo M Daval, et al. 2009 Successful versus failed adaptation to high-fat diet-induced insulin resistance: the role of IAPP-induced beta-cell endoplasmic reticulum stress Diabetes 58 4 906 916 10.2337/db08-1464 1:CAS:528:DC%2BD1MXktleiurk%3D 19151199
20. D Porte Jr SE Kahn 1989 Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction? Diabetes 38 1333 1336 10.2337/diabetes.38.11.1333 1:CAS:528:DyaK3cXlsVeh 2695369
21. P Westermark U Engstrom GT Westermark, et al. 1989 Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans Diabetes Res Clin Pract 7 219 226 10.1016/0168-8227(89)90008-9 1:CAS:528:DyaL1MXmtV2nt78%3D 2691219 (Pubitemid 19231484)
22. X Hou Z Ling E Quartier, et al. 1999 Prolonged exposure of pancreatic beta cells to raised glucose concentrations results in increased cellular content of islet amyloid polypeptide precursors Diabetologia 42 188 194 10.1007/s001250051138 1:CAS:528:DyaK1MXhtFajtr0%3D 10064099 (Pubitemid 29064241)
23. L Marzban CJ Rhodes DF Steiner, et al. 2006 Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death Diabetes 55 8 2192 2201 10.2337/db05-1566 1:CAS:528:DC%2BD28Xot1Ogtb0%3D 16873681 (Pubitemid 44743615)
24. J Wang J Xu J Finnerty, et al. 2001 The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site Diabetes 50 3 534 539 10.2337/diabetes.50.3.534 1:CAS:528:DC%2BD3MXhslGhu70%3D 11246872
25. L Marzban K Park CB Verchere 2003 Islet amyloid polypeptide and type 2 diabetes Exp Gerontol 38 347 351 10.1016/S0531-5565(03)00004-4 1:CAS:528:DC%2BD3sXisV2lu7s%3D 12670620 (Pubitemid 36379069)
26. M Krampert J Bernhagen J Schmucker, et al. 2000 Amyloidogenicity of recombinant human proislet amyloid polypeptide (ProIAPP) Chem Biol 7 855 871 10.1016/S1074-5521(00)00034-X 1:CAS:528:DC%2BD3cXosVWitL8%3D 11094339
27. JF Paulsson A Andersson P Westermark, et al. 2006 Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets Diabetologia 49 1237 1246 10.1007/s00125-006-0206-7 1:CAS:528:DC%2BD28Xktlaltbw%3D 16570161
28. KG Alberti PZ Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation Diabetes Med 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 1:STN:280:DyaK1czkvFCrsA%3D%3D (Pubitemid 28319935)
29. Jha S, Sellin D, Seidel R, et al (2009) Amyloidogenic propensities and conformational properties of ProIAPP and IAPP in the presence of lipid bilayer membranes. J Mol Biol 26; 389(5):907-920
30. RL Hull GT Westermark P Westermark, et al. 2004 Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes J Clin Endocrinol Metab 89 3629 3643 10.1210/jc.2004-0405 1:CAS:528:DC%2BD2cXmslKmsb0%3D 15292279 (Pubitemid 39071447)
31. C Alarcon JL Leahy GT Schuppin, et al. 1995 Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulindependent diabetes mellitus J Clin Invest 95 1032 1039 10.1172/JCI117748 1:CAS:528:DyaK2MXktlKhtL0%3D 7883951
32. J Janson RH Ashley D Harrison, et al. 1999 The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediatesized toxic amyloid particles Diabetes 48 491 498 10.2337/diabetes.48.3.491 1:CAS:528: DyaK1MXhsFymsbk%3D 10078548
33. AE Butler J Janson WC Soeller, et al. 2003 Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 2304 2314 10.2337/diabetes.52.9.2304 1:CAS:528:DC%2BD3sXntFeqtbY%3D 12941770 (Pubitemid 37059501)
34. A Demuro E Mina R Kayed, et al. 2005 Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers J Biol Chem 280 17294 17300 10.1074/jbc.M500997200 1:CAS:528:DC%2BD2MXjsFOguro%3D 15722360 (Pubitemid 41389198)
35. DM Skovronsky VM-Y Lee JQ Trojanowski 2006 Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications Annu Rev Pathol Mech Dis 1 151 170 10.1146/annurev.pathol.1.110304.100113 1:CAS:528: DC%2BD28XktVOitbo%3D
36. JF Paulsson GT Westermark 2005 Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation Diabetes 54 7 2117 2125 10.2337/diabetes.54.7.2117 1:CAS:528:DC%2BD2MXmtVeltr8%3D 15983213 (Pubitemid 40911275)